INTERNATIONAL PATENT: SYNERK BIOPHARMACEUTICALS LIMITED, 施能康生物医药（苏州）有限公司 FILES APPLICATION FOR "NUCLEIC ACID TARGETING INHIBIN SUBUNIT ΒE AND USE THEREOF"

Posted On: 2025-10-04

GENEVA, Oct. 4 -- SYNERK BIOPHARMACEUTICALS LIMITED (218 Xinghu Street, B3-301, Suzhou Industrial ParkSuzhou, Jiangsu 215123), 施能康生物医药（苏州）有限公司 (中国江苏省苏州市自由贸易试验区苏州片区苏州工业园区星湖街218号生物医药产业园一期B3楼301单元) filed a patent application (PCT/CN2025/085076) for "NUCLEIC ACID TARGETING INHIBIN SUBUNIT BetaE AND USE THEREOF" on Mar 26, 2025. With publication no. WO/2025/201...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SYNERK BIOPHARMACEUTICALS LIMITED, 施能康生物医药（苏州）有限公司 FILES APPLICATION FOR "NUCLEIC ACID TARGETING INHIBIN SUBUNIT ΒE AND USE THEREOF"